Texas · Senate Bill 426 · 88th Legislature, Regular Session
Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.
SB 426Sponsored by
Angela PaxtonPassed one chamber, then died
IntroducedJan 12, 2023
In committeeFeb 15, 2023
Passed the SenateApr 5, 2023
Died
To the governor
Became law
Every action
31 steps, oldest first, as the legislature records them.
Show the 23 earlier steps
SenateReceived by the Secretary of the Senate
SenateFiled
SenateRead first time
SenateReferred to Health & Human Services
CommitteeScheduled for public hearing on . . . · Senate Health & Human Services
CommitteeConsidered in public hearing · Senate Health & Human Services
CommitteeTestimony taken in committee · Senate Health & Human Services
CommitteeLeft pending in committee · Senate Health & Human Services
SenateCo-author authorized
CommitteeConsidered in public hearing · Senate Health & Human Services
CommitteeVote taken in committee · Senate Health & Human Services
CommitteeReported favorably w/o amendments · Senate Health & Human Services
SenateCommittee report printed and distributed
SenatePlaced on intent calendar
SenateRules suspended-Regular order of business
SenateVote recorded in Journal
SenateRead 2nd time
SenateAmendment(s) offered (FA1 Paxton)
SenateAmended
SenateVote recorded in Journal
SenatePassed to engrossment as amended
SenateVote recorded in Journal
SenateThree day rule suspended
SenateRecord vote
SenateRead 3rd time
SenatePassed
SenateRecord vote
SenateReported engrossed
HouseReceived from the Senate
HouseRead first time
CommitteeReferred to Public Health · House Public Health
Roll calls
3 recorded votes: 2 on the floor, 1 in committee. Each shows how every member voted.
Senator Paxton moved that Senate Rule 7.18 and the Constitutional Rule requiring bills to be read on three several days be suspended and that SB 426 be placed on its third reading and final passage. — The motion prevailed · Full Senate